of the Institute of Genetics and Genomics of Geneva (known also as iGE3). Distinctions Dermitzakis has published over 160 papers in peer-reviewed scientific journals such as Nature and Science with over 89,000 citations. Before the age of 40 he was already on the Thomson Reuters Highly Cited Researchers list in the field of Molecular Biology and Genetics. His research has been funded by the European Research Council (ERC), the European Union, the Swiss National Science Foundation, the American National Institutes of Health (NIH), the Wellcome Trust, the Juvenile Diabetes Research Foundation (JDRF) and the Louis-Jeantet Foundation. Dermitzakis has earned numerous awards and continues to appear on the ISI Highly Cited Researchers List every year from 2014 onward. Scientific contributions Dermitzakis has been one of the first scientists to reveal the importance of non-coding DNA in evolution and disease susceptibility. His seminal papers on the evolution of regulatory elements showed the dynamic nature of regulatory sequences. His group has pioneered the analysis of non-coding regulatory variants in the human genome and their effect on gene expression regulation, chromatin patterns and regulatory interactions and 3D genome interactions in cis and trans regulatory variants and how they are impacting cellular function as well as disease susceptibility and cancer. He played a leading role in many major international genetics projects such as ENCODE, HapMap, GTEx and more recently in the International Common Disease Alliance (ICDA). Personal life Manolis Dermitzakis is married to attorney Ria Kechagia and the couple have three children. References External links Faculty page 1972 births Living people Greek geneticists Greek emigrants to Switzerland Members of the European Molecular Biology Organization Academic staff of the University of Geneva University of Crete alumni Eberly College of Science alumni Scientists from Athens